The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, How Much Growth In Market Size Is Expected For The Computer-Aided Drug Discovery Market?
The computer-aided drug discovery market has seen rapid expansion in recent years. It is projected to grow from $7.56 billion in 2025 to $8.54 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 12.9%. Historically, this expansion has been driven by factors such as the increasing intricacy of drug development processes, greater investment in pharmaceutical research and development, the broadening scope of computational biology capabilities, the increasing volume of accessible biological data, and the incorporation of in silico modeling techniques.
The computer-aided drug discovery market is anticipated to experience significant expansion in the near future. Its valuation is projected to reach $13.69 billion by 2030, progressing at a compound annual growth rate (CAGR) of 12.5%. The projected growth is driven by several factors, including greater investments in AI-enabled drug discovery, an increasing need for expedited drug development processes, the widening scope of personalized medicine research, the deeper integration of machine learning in pharmacology, and an expanded utilization of cloud computing for extensive simulations. Prominent developments expected throughout this period encompass a rise in the application of AI-driven virtual screening, increased adoption of molecular docking simulations, more extensive integration of genomic data into drug design, the growth of cloud-based drug discovery platforms, and a stronger emphasis on the accuracy of predictive modeling.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19379&type=smp
What Market Drivers Are Helping Shape The Computer-Aided Drug Discovery Market Expansion?
The increasing incidence of cancer is anticipated to fuel the expansion of the computer-aided drug discovery market. Cancer, characterized by the unregulated proliferation and division of abnormal cells, sees its rising prevalence attributed to factors like lifestyle shifts, urbanization, environmental contamination, tobacco and alcohol use, and issues with healthcare accessibility and public awareness. Computer-aided drug discovery offers a means to develop drugs specifically targeting cancer cells with unique genetic mutations, thereby enabling more personalized and effective cancer treatments. For instance, data from July 2024, released by the Australian Institute of Health and Welfare, an Australia-based government agency, revealed approximately 165,000 new cancer cases were diagnosed in 2023. This figure is projected to rise to about 204,000 cases annually by 2033, contributing to an estimated total of 1.9 million cancer cases between 2024 and 2033. Thus, the escalating prevalence of cancer cases is a key driver for the computer-aided drug discovery market.
Which Segment Divisions Form The Structure Of The Computer-Aided Drug Discovery Market?
The computer-aided drug discovery market covered in this report is segmented –
1) By Type: Structure Based Drug Design, Ligand-Based Drug Design, Sequence-Based Approaches
2) By Therapeutic Area: Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, Other Therapeutic Areas
3) By End User: Pharmaceutical Companies, Biotechnology Companies, Research Laboratories
Subsegments:
1) By Structure Based Drug Design: X-ray Crystallography, Nuclear Magnetic Resonance (NMR) Spectroscopy, Molecular Docking Studies, Virtual Screening
2) By Ligand-Based Drug Design: Quantitative Structure-Activity Relationship (QSAR) Models, Pharmacophore Modeling, Ligand Similarity Searching, Fragment-Based Drug Design
3) By Sequence-Based Approaches: Protein Structure Prediction, Homology Modeling, Bioinformatics for Drug Target Identification, Genomic Data Analysis for Drug Discovery
What Trends Are Affecting The Computer-Aided Drug Discovery Market Dynamics?
Major companies in the computer-aided drug discovery (CADD) market are creating innovative solutions, including artificial intelligence in drug discovery, to boost the accuracy, speed, and efficiency of identifying potential drug candidates, refining lead compounds, and facilitating personalized medicine development. Artificial intelligence (AI) in drug discovery refers to the application of AI technologies like machine learning and deep learning, utilizing advanced algorithms to make the discovery and development of new drugs quicker, more efficient, and more exact. As an illustration, in December 2023, Merck KGaA, a Germany-based science and technology company, unveiled AIDDISONTM, the first software-as-a-service platform designed to integrate drug discovery and synthesis. By combining generative AI, machine learning, and computer-aided drug design, AIDDISONTM accelerates drug development through the virtual screening of compounds from over 60 billion chemical targets and the recommendation of optimal synthesis routes. The platform has been trained on two decades of pharmaceutical R&D data to identify drug-like candidates with desirable attributes such as non-toxicity and stability. Moreover, by incorporating Merck’s SynthiaTM retrosynthesis API, AIDDISONTM enhances drug manufacturing for improved efficiency and sustainability, with the objective of lowering the cost and time associated with drug discovery.
Which Companies Form The Competitive Landscape Of The Computer-Aided Drug Discovery Market?
Major companies operating in the computer-aided drug discovery market are Dassault Systèmes SE, PerkinElmer Inc., Roivant Sciences Ltd., Certara Inc., Schrödinger Inc., XtalPi Inc., Dotmatics Limited, Simulations Plus Inc., ChemAxon Ltd., Exscientia Ltd., Insilico Medicine Inc., Collaborative Drug Discovery Inc., OpenEye Scientific Software Inc., Nimbus Therapeutics LLC, Atomwise Inc., GNS Healthcare Inc., BenevolentAI Limited, EpiVax Inc., Numerate Inc., Cloud Pharmaceuticals Inc., Aris Pharmaceuticals Inc., Cyclica Inc., BioSolveIT GmbH, Chemical Computing Group ULC, InSilicoTrials Technologies S.p.A
Access The Complete Computer-Aided Drug Discovery Market Report:
https://www.thebusinessresearchcompany.com/report/computer-aided-drug-discovery-global-market-report
Which Region Leads The Computer-Aided Drug Discovery Market By Size?
North America was the largest region in the computer-aided drug discovery (CADD) market in 2025. The regions covered in the computer-aided drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Computer-Aided Drug Discovery Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=19379&type=smp
Browse Through More Reports Similar to the Global Computer-Aided Drug Discovery Market 2026, By The Business Research Company
Artificial Intelligence In Healthcare Diagnosis Global Market Report 2026
Diagnostic Contract Manufacturing Global Market Report 2026
Ai In Medical Diagnostics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-medical-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model